Sierra White

8PUBLICATIONS
45CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Fluid-structure interaction and aeroacoustics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 30, 2026
The chemotherapy-induced senescence-associated secretome promotes cell detachment and metastatic dissemination through metabolic reprogramming.

|Apr 16, 2026
RHOV Is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis.

|Aug 20, 2025
RHOV is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis.

Amal T Elhaw, Priscilla W Tang, Ya-Yun Cheng

|Jul 09, 2025
Loss of Predicted Cell Adhesion Molecule MPZL3 Promotes EMT in Ovarian Cancer.

Ya-Yun Cheng, Beth L Worley, Zaineb Javed

|Nov 28, 2024
Loss of the predicted cell adhesion molecule MPZL3 promotes EMT and chemoresistance in ovarian cancer.

Ya-Yun Cheng, Beth L Worley, Zaineb Javed

|Feb 14, 2024
GPX3 supports ovarian cancer tumor progression in vivo and promotes expression of GDF15.

Caroline Chang, Ya-Yun Cheng, Shriya Kamlapurkar

Pageof 2

Frequent Collaborators

7 joint publications

Amal Taher Elhaw

7 joint publications

Katherine M Aird

6 joint publications

Zaineb Javed

6 joint publications

Shriya Kamlapurkar